“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: P.30 The relation between the abnormality of the P53 gene and the epidemiological and biological parameters
P.30 The relation between the abnormality of the P53 gene and the epidemiological and biological parameters
Reviews
There are no reviews yet.
Be the first to review “Article: P.30 The relation between the abnormality of the P53 gene and the epidemiological and biological parameters” Cancel reply
Reviews
There are no reviews yet.